<DOC>
	<DOCNO>NCT01171365</DOCNO>
	<brief_summary>The purpose study determine whether inhaled steroid small particle size additional treatment option patient refractory eosinophilic asthma .</brief_summary>
	<brief_title>Small Particle Steroids Refractory Asthma</brief_title>
	<detailed_description>We identify group patient refractory asthma ongoing eosinophilic airway inflammation despite high dose inhale corticosteroid . Traditional inhaled steroid relatively proximal airway distribution may lead inadequate treatment distal airway . We aim demonstrate steroid inhaler small particle size target distal airways useful additional treatment option group patient .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Age 1880 ACQ &gt; 1.5 requirement oral steroid twice year High dose inhale steroid ( &gt; 1000mcg BDP equivalent ) Treatment unsuccessful trial : longacting beta agonist leukotriene antagonist Sputum eosinophil count &gt; 3 % despite high dose inhale steroid &gt; 2 % serum eosinophils &gt; 0.4x10exp9/l Clinical response 2 week oral prednisolone : ( one ) reduction ACQ 0.5 increase FEV1 200ml normalisation exhale nitric oxide reduction &gt; 25ppb Current smoker , exsmoker &lt; 12 month Current treatment extrafine steroid inhaler Respiratory infection within last 4 week Pregnancy lactation Poor compliance usual asthma medication Clinical diagnosis significant bronchiectasis Use medication may interact ciclesonide : ketoconazole itraconazole ritonavir , nelfinavir</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Ciclesonide</keyword>
	<keyword>Asthma</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pulmonary Eosinophilia</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
</DOC>